Compare Stocks/Companies in India by Industry/Sectors and Index (Page 1)

Company Name	Industry Name	Latest Price (Rs.)	Price Change Rs (%)	Market Cap	Net Sales (Rs. Cr.)	Latest EPS (Rs.)	Net Profit Margin %	Latest P/E	Latest P/BV
360 One Wam	Finance - Stock Broking	1,056.3	-17.95 (-1.67%)	Mid Cap	232	9.7	144.16	108.6	5.8
3M India	Diversified	31,533.4	-492.55 (-1.54%)	Mid Cap	4,446	463.7	10.87	68	20.1
Abbott India	Pharmaceuticals & Drugs	25,793	-224.7 (-0.86%)	Mid Cap	6,409	730.4	22.1	35.3	11.5
Adani Total Gas	Gas Transmission/Mar keting	734.5	-27.75 (-3.64%)	Mid Cap	5,894	6	10.08	123.2	16.6
Aditya Birla Capital	Finance - NBFC	344	-13.55 (-3.79%)	Mid Cap	40,590	14.4	8.33	24	2.6
AIA Engineering	Castings/Forging s	4,544.1	-87.1 (-1.88%)	Mid Cap	4,287	136.1	23.86	33.4	5.3
Ajanta Pharma	Pharmaceuticals & Drugs	2,970	-7.6 (-0.26%)	Mid Cap	4,648	84.5	19.35	35.1	8.2
Alkem Laboratories	Pharmaceuticals & Drugs	5,351.7	100.4 (1.91%)	Mid Cap	8,813	182.8	23.18	29.3	4.6
Anthem Biosciences	Pharmaceuticals & Drugs	773.5	11.55 (1.52%)	Mid Cap	1,841	11.9	27.24	65	13.7
Apar Inds	Electric Equipment	13,271.3	-598.45 (-4.31%)	Mid Cap	18,581	243.2	4.38	54.6	9.9
APL Apollo Tubes	Steel & Iron Products	1,822.6	-1.65 (-0.09%)	Mid Cap	20,690	43.3	3.57	42.1	9.6
Ashok Leyland	Automobiles-Truc ks/Lcv	141	-4.35 (-2.99%)	Mid Cap	38,753	6.1	8.22	23.2	6.3
Astral	Plastic Products	1,509	-9.45 (-0.62%)	Mid Cap	5,832	20	8.79	75.6	10
AU Small Fin. Bank	Bank - Private	958.4	-10.4 (-1.07%)	Mid Cap	1,429	24.3	53.23	39.5	-
Aurobindo Pharma	Pharmaceuticals & Drugs	1,451.9	-10.7 (-0.73%)	Mid Cap	10,933	42	15.17	34.6	3.7
Authum Inv. & Infra	Finance - Investment	456.3	-5.9 (-1.28%)	Mid Cap	4,566	22.6	93.04	20.2	2.7
Bajaj Housing Financ	Finance - Housing	82.6	-1.5 (-1.78%)	Mid Cap	9,576	3.1	22.59	26.9	3.1
Balkrishna Inds.	Tyres & Allied	2,094.5	-48.2 (-2.25%)	Mid Cap	10,413	63.2	13.08	33.1	3.7
Bank Of India	Bank - Public	139.8	-1.7 (-1.2%)	Mid Cap	75,613	22.6	13.34	6.2	0.8
Bank of Maharashtra	Bank - Public	79.6	0.46 (0.58%)	Mid Cap	24,947	9.1	22.13	8.7	2
Berger Paints India	Paints	491.1	0.9 (0.18%)	Mid Cap	11,545	9.7	10.24	50.8	8.3
Bharat Dynamics	Defence	1,186.8	-20.55 (-1.7%)	Mid Cap	0	-	-	-	-
Bharat Forge	Forgings	1,894.3	-36.15 (-1.87%)	Mid Cap	15,123	22.6	6.56	83.9	9.5
Bharti Hexacom Ltd.	Telecommunicatio n - Service Provider	1,457.3	-22.55 (-1.52%)	Mid Cap	8,548	34.7	15.61	42	10.2
BHEL	Engineering - Industrial Equipments	386	-1 (-0.26%)	Mid Cap	28,339	4.5	1.43	85.2	5.1

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

ComPeer - Compare Stocks

Find out the best companies in the Industry/ Sector/ Index of your choice, based on critical criteria.

Select a category :

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.